Chronic Disease
Featured Topics
Lead story
Other featured articles
-
PNAS: Decoding the Mystery of American Pain Reveals a Warning for the Future
In America today, the elderly report less pain than those in midlife. This is the mystery of American pain.
Posted in -
The “Advancing American Kidney Health” Executive Order: Challenges and Opportunities for the Large Dialysis Organizations
This perspective in the American Journal of Kidney Diseases examines how the “Advancing American Kidney Health” Executive Order (AAKH) might reshape the US dialysis market.
Posted in -
Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model
There is a significant burden of disease among individuals with CHD; the disease affects quality of life, disability, life expectancy, medical spending, chronic disease, as well as employment and education outcomes.
Posted in -
California Leads in Public Investment in Biomedical Innovation and It Is Beginning to Show Returns
Schaeffer Center research indicates public investment into biomedical innovation yields substantial economic and social return in California.
Posted in
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Our Experts On Chronic Disease
Our Work In Chronic Disease
-
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Categorized in -
Early Delays in Insurance Coverage and Long- Term Use of Home- Based Peritoneal Dialysis
The study analyzes Medicare coverage delays among the uninsured and their effect on long-term peritoneal dialysis use.
Categorized in -
Early Detection: A New Front in the War on Cancer
Blood tests that find malignancies before they spread couldtransform our approach to treatment, Goldman wrote in Scientific American.
Categorized in -
Association of Combination Statin and Antihypertensive Therapy With Reduced Alzheimer’s Disease and Related Dementia Risk
Drugs already being used to treat high blood pressure and cholesterol could reduce the risk of Alzheimer’s disease and dementia, according to a new Schaeffer Center study of nearly 700,000 Medicare beneficiaries.
Categorized in -
A Checklist to Help Prevent and Manage Pressure Injury
Schaeffer Fellow William Padula and colleagues developed a simple protocol to prevent and manage pressure injury referenced in Federal Appropriations Legislative Package.
Categorized in -
Obesity, Second to Smoking as the Most Preventable Cause of US Deaths, Needs New Approaches
Nearly 40% of Americans are obese, and the numbers are climbing. The U.S. needs to get serious about solutions.
Categorized in